Last updated: 17 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stem cell treatment for retinitis pigmentosa is one of the most searched questions among families living with inherited vision loss. The honest short answer is that it
Last updated: 15 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Optic nerve hypoplasia treatment is centred on early diagnosis, protecting vision development and checking for hormone and brain-related problems that often go with the condition. Optic nerve
Last updated: 10 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience ONH treatment for children with optic nerve hypoplasia is a long-term partnership between parents, doctors and therapists. There is no single procedure that fixes the condition, but
Last updated: 9 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stem cell treatment in India attracts many patients with inherited and degenerative eye disease, especially those who have been told that conventional options are exhausted. India has
Last updated: 5 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stem cell therapy in India is easier to judge once you understand the basics: which cells are used, where they come from, how they are delivered and
Last updated: 3 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stem cell treatment for eye disease is a fast-moving research field, and it is easy to confuse hope with evidence. A few procedures, such as limbal stem
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Diabetic Retinopathy is one of the most common diabetes-related eye complications and a leading cause of vision impairment among adults. High blood sugar levels can damage the tiny blood vessels
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Unlike many stem cell treatments still confined to research trials, corneal stem cell therapy for limbal stem cell deficiency (LSCD) is one of the few genuinely established, evidence-backed regenerative treatments
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Diabetic retinopathy is one of the most common complications of long-standing diabetes and remains a leading cause of vision loss among working-age adults worldwide. As blood sugar levels stay elevated
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience This is one of the most direct questions patients ask when researching stem cell treatment for eye conditions, and it deserves an equally direct, evidence-grounded answer rather than a hopeful

